Characteristics | 2013–2015 (N = 12,599) | 2017–2019 (N = 8216) | 2020–2022 (N = 3348) | P1 value | P2 value |
---|---|---|---|---|---|
Gender, n(%) | 0.019a | 0.334a | |||
Male | 7317 (58.08) | 4636 (56.43) | 1922 (57.41) | ||
Female | 5282 (41.92) | 3580 (43.57) | 1426 (42.59) | ||
Male Female | 1.39 | 1.29 | 1.34 | ||
Median age, month (P25, P75) | 26 (16–36) | 25 (15–36) | 25 (16–36) | 0.331b | < 0.001b |
Age group,month, n (%) | < 0.001a | < 0.001a | |||
0–11 | 1335 (10.60) | 1069 (13.01) | 372 (11.11) | ||
12–23 | 4329 (34.36) | 2868 (34.91) | 1170 (34.95) | ||
24–47 | 5658 (44.91) | 3105 (37.79) | 1201 (35.87) | ||
> 48 | 1277 (10.14) | 1174 (14.29) | 605 (18.07) | ||
Serotypes, n (%) | < 0.001a | < 0.001a | |||
EV-A71 | 1713 (13.60) | 150 (1.83) | 0 (0) | ||
CV.A16 | 1759 (13.96) | 891 (10.84) | 152 (4.54) | ||
Other enterovirus 1 | 9127 (72.44) | 7175 (87.33) | 3196 (95.45) | ||
CV-A6 | – | – | 1687 (50.39) | ||
CV-A10 | – | – | 362 (10.81) | ||
Other enterovirus 2 | – | – | 1147 (34.26) | ||
In/outpatient, n (%) | < 0.001a | 0.020a | |||
Inpatient | 1061 (8.42) | 390 (6.73) | 126 (3.76) | ||
Outpatient | 11,538 (91.58) | 7826 (93.27) | 3222 (96.24) |